Page 86 - Htain Manual

possible data to be generated, or make the best possible decision (using a model) with the

available data! The option to revisit the decision when better data is generated is always

open.

References

1. Fox-Rushby J, Cairns J. Economic evaluation. London: Oxford University Press; 2006
2. Gupta M, Prinja S, Kaur M, Kumar R. Cost effectiveness of Hib vaccine for
introduction in national immunization schedule in Haryana state, India. Health Policy
and Planning. 2013 Jan;28(1):51-61. doi: 10.1093/heapol/czs025.
3. Prinja S, Bahuguna, Faujdar DS, Jyani G, Srinivasan R, Ghoshal S, Suri V, Singh MP,
Kumar R. Reply to Cost-effectiveness calculations of human papillomavirus
vaccination in Punjab may be flawed. Cancer. 2018 Jan 1;124(1):214-216.
4. Gupta N, Verma R, Prinja S, Dhiman RK. Cost Effectiveness of Sorafenib for
Treatment of Advanced Hepatocellular Carcinoma in India. Journal of Clinical and

Experimental Hepatology. 2018. Forthcoming.
5. Prinja S, Chauhan AS, Angell B, Gupta I, Jan S. A Systematic Review of the State of
Economic Evaluation for Health Care in India. Appl Health Econ Health Policy. 2015
Dec;13(6):595-613.

74